551944-18-4Relevant articles and documents
ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF
-
, (2019/11/28)
Provided herein are antibodies and antigen-binding fragments that bind MSR1 and methods of use thereof. According to certain embodiments, the antibodies bind human MSR1 with high affinity. In certain embodiments, the antibodies bind MSR1 without blocking, or blocking less than 90%, of modified LDL binding to MSR1. In some embodiments, the antibodies bind cell surface expressed-MSR1 and are internalized. The antibodies of the invention may be fully human antibodies. The invention includes anti-MSR1 antibodies, or antigen-binding fragments thereof, conjugated to drugs or therapeutic compounds.
BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF
-
, (2018/12/04)
Provided herein are compounds, compositions and methods for the treatment of diseases and disorders associated with the liver X receptor, including bis-octahydrophenanthrene carboxamides and protein (e.g., antibody) drug conjugates thereof.
Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis
Liu, Weiguo,Chen, Steve,Dropinski, James,Colwell, Lawrence,Robins, Michael,Szymonifka, Michael,Hayes, Nancy,Sharma, Neelam,MacNaul, Karen,Hernandez, Melba,Burton, Charlotte,Sparrow, Carl P.,Menke, John G.,Singh, Sheo B.
, p. 4574 - 4578 (2007/10/03)
A series of podocarpic acid amides were identified as potent agonists for Liver X receptor α and β subtypes, which are members of a nuclear hormone receptor superfamily that are involved in the regulation of a variety of metabolic pathways including chole